Ménière's disease: Difference between revisions

Jump to navigation Jump to search
(Undo revision 1634127 by SuFurniturewala (talk))
Tag: Undo
No edit summary
 
(17 intermediate revisions by 2 users not shown)
Line 18: Line 18:
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''


{{CMG}}
{{CMG}} {{AE}}{{SUF}}


==Overview==
==Overview ==
'''Ménière's disease''' is a disorder of the [[inner ear]] that can affect [[Hearing (sense)|hearing]] and balance. It is characterized by episodes of [[dizziness]] and [[tinnitus]] and progressive hearing loss, usually in one ear. It is caused by an increase in volume and pressure of the [[endolymph]] of the inner ear. It is named after the French physician [[Prosper Ménière]], who first reported that [[Vertigo (medical)|vertigo]] was caused by inner ear disorders in an article published in 1861.<ref>{{WhoNamedIt|synd|2073|Ménière's disease}}</ref>
'''Ménière's disease''' is a disorder affecting the sensory organ within the [[inner ear]] responsible for balance and hearing. It is characterized by episodes of [[dizziness]], [[tinnitus]] and progressive hearing loss, usually in one ear. This disturbance in the normal physiological functioning of the inner ear can be attributed to an increase in volume and pressure in the [[endolymph]] of the inner ear. The term "Ménière's" takes it origin after the French physician [[Prosper Ménière]], who first reported that [[Vertigo (medical)|vertigo]] was caused by disorders of the inner ear in an article published in 1861.


==Historical Background==
==Historical Background==
Ménière's disease had been recognized prior to 1972, but it was still relatively vague and broad at the time. Committees at the Academy of Ophthalmology and Otolaryngology made set critera for diagnosing Ménière's, as well as defining two sub categories of Ménière's: cochlear (without vertigo) and vestibular (without deafness).
Ménière's disease had been recognized prior to 1972 but the information available on its prevalence and understanding remained rather vague. Committees at the Academy of Ophthalmology and Otolaryngology made set criteria for diagnosing Ménière's, as well as defining two sub categories of Ménière's: cochlear (without vertigo) and vestibular (without deafness).


In 1972, the academy defined critera for diagnosing Ménière's disease as:
In 1972, the academy defined criteria for diagnosing Ménière's disease as:
#Fluctuating, progressive, sensorineural deafness.
#Fluctuating, progressive, sensorineural deafness.
#Episodic, characteristic definitive spells of vertigo lasting 20 minutes to 24 hours with no unconsciousness, vestibular [[nystagmus]] always present.
#Episodic, characteristic definitive spells of vertigo lasting 20 minutes to 24 hours without loss of consciousness and associated with the presence of vestibular nystagmus .
#Usually tinnitus.
#Usually tinnitus.
#Attacks are characterized by periods of remission and exacerbation.
#Attacks are characterized by periods of remission and exacerbation.


In 1985, this list changed to alter wording, such as changing "deafness" to "hearing loss associated with tinnitus, characteristically of low frequencies" and requiring more than one attack of vertigo to diagnose.  Finally in 1995, the list was again altered to allow for degrees of the disease:
In 1985, this list changed to alter wording, such as "deafness" changed to "hearing loss associated with tinnitus, characteristic of low frequencies" and requiring more than one attack of vertigo to diagnose.  Finally in 1995, the list was again altered to allow for its documentation based on various degrees of probability of having the disease:
# Certain - Definite disease with [[Histopathology|histopathological]] confirmation
# Certain - Definite disease with [[Histopathology|histopathological]] confirmation
# Definite - Requires two or more definitive episodes of vertigo with hearing loss plus tinnitus and/or aural fullness
# Definite - Requires two or more definitive episodes of vertigo with hearing loss plus tinnitus and/or aural fullness
# Probable - Only one definitive episode of vertigo and the other symptoms and signs
# Probable - Only one definitive episode of vertigo and the other symptoms and signs
# Possible - Definitive vertigo with no associated hearing loss<ref name="BJones">{{Citation
# Possible - Definitive vertigo with no associated hearing loss
  | last = Beasley
  | last2 = Jones
  | title = Meniere's disease: Evolution of a definition
  | journal = The Journal of Laryngology and Otology
  | volume = 110
  | issue = 12
  | pages = 1107-13
  | date = December
  | year = 1996}}</ref>


==Cause==
==Cause==
The exact cause of Ménière's disease is not known, but it is believed to be related to ''endolymphatic hydrops'' or excess fluid in the inner ear.  It is thought that endolymphatic fluid bursts from its normal channels in the ear and flows into other areas causing damage.  This may be related to swelling of the [[endolymphatic sac]] or other tissues in the [[vestibular system]] of the inner ear, which is responsible for the body's sense of balance. The symptoms may occur in the presence of a [[middle ear]] [[infection]], [[head trauma]] or an [[upper respiratory tract infection]], or by using [[aspirin]], smoking [[cigarette]]s or drinking alcohol. They may be further exacerbated by excessive consumption of [[caffeine]] and [[salt]] in some patients. Excessive levels of [[potassium]] in the body (usually caused by the consumption of potassium rich foods) may also exacerbate the symptoms.


It has also been proposed that Ménière's symptoms are the result of damage caused by a herpes virus <ref name=" Shichinohe ">"Effectiveness of Acyclovir on Meniere's Syndrome III Observation of Clinical Symptoms in 301 cases," Mitsuo Shichinohe, M.D., Ph.D., ''The Sapporo Medical Journal'', Vol. 68, No. 4-6, December, 1999.</ref><ref name="pmid11464320">{{cite journal |author=Richard R. Gacek, MD and Mark R. Gacek, MD |title= Menière"s Disease as a Manifestation of Vestibular Ganglionitis |journal= American Journal of Otolaryngology. |volume=22 |issue=4 |pages=441–250 |year=2001 |pmid=11464320 }}</ref>. [[Herpesviridae]] are present in a majority of the population in a dormant state. It is suggested that the virus is reactivated when the immune system is depressed due to a stressor such as trauma, infection or surgery (under general anaesthesia). Symptoms then develop as the virus degrades the structure of the inner ear.  
* Physiological -The exact cause of Ménière's disease is not known, but it is believed to be related to ''endolymphatic hydrops'' or excessive fluid in the inner ear. Several theories describing the causative mechanism have been proposed and documented, One such theory includes the decreased absorption or the increased production of the endolymph within the endolymphatic sac. This in-turn contributes to the swelling of the [[endolymphatic sac]] or other tissues in the [[vestibular system]] of the inner ear, a system responsible for the body's sense of balance which is disrupted a s a result of this pathology.
 
* Anatomical - Longitudinal blockage in the structures responsible for the drainage of the endolymph causing an increase in the hydrostatic pressure within the endolymphatic sac was another theory that was proposed to describe the possible structural cause behind the disease.
* Head trauma
* Infectious - It has also been proposed that Ménière's symptoms could be the result of damage caused by a the large family of DNA virus, [[herpesviridae]]. [[Herpesviridae]] is prevalent in the dormant state in a majority of the population. It is suggested that the virus is reactivated when the immune system is depressed due to stressors such as trauma, infection or surgery (under general anaesthesia). Morphological changes to the inner ear of Ménière's sufferers has  been found and is likely considered to have resulted from attack by the [[herpes simplex virus|herpes simplex virus.]] Symptoms then develop as the virus degrades the structure of the inner ear. Another consideration of  utmost importance is that the different strains of herpes virus have different characteristics and in-turn different pathophysiological effects on the inner ear sensory organ system.
* Middle ear and Upper Respiratory Tract Infections.
* Medications - Aspirin use
* Substance use - Tobacco and alcohol use
 
* Electrolyte imbalance - Excessive levels of [[potassium]] in the body (usually caused by the consumption of potassium rich foods)can also exacerbate these symptoms.


==Symptoms==
==Symptoms==
The symptoms of Ménière's are variable; not all sufferers experience the same symptoms.  However, so-called "classic Ménière's" is considered to comprise the following four symptoms:  
The symptoms of Ménière's are variable; not all sufferers experience the same symptoms.  However, so-called "classic Ménière's" is considered to comprise of  the following four symptoms:  
* Periodic episodes of rotary [[Vertigo (medical)|vertigo]] (the abnormal sensation of movement) or dizziness.
* Fluctuating, progressive, unilateral (in one [[ear]]) or bilateral (in both ears) [[hearing loss]], often initially in the lower frequency ranges.
* Unilateral or bilateral [[tinnitus]] (the perception of noises, often ringing, roaring, or whooshing), sometimes variable.
* A sensation of fullness or pressure in one or both ears.


Ménière's often begins with one symptom, and gradually progresses.  A diagnosis may be made in the absence of all four classic symptoms.<ref>{{cite web | url=http://www.tinnitus.org/home/frame/meniere.htm | title = Information on Ménière's Syndrome" | first=Jonathan | last=Hazell | accessdate=2007-02-27}}</ref>  However, having several symptoms at once is more  conclusive than having each individual symptom had separate times.<ref name="Maryland">{{cite web |publisher=Maryland Hearing and Balance Center |title=Meniérè's disease |url=http://www.umm.edu/otolaryngology/menieres_disease.html |accessdate=2008-03-03}}</ref>
# Periodic episodes of rotary [[Vertigo (medical)|vertigo]] (the abnormal sensation of movement) or dizziness.
# Fluctuating, progressive, unilateral (in one [[ear]]) or bilateral (in both ears) [[hearing loss]], sensorineural in origin and often initially in the low frequency ranges.
# Unilateral or bilateral [[tinnitus]] (the perception of noises, often ringing, roaring, or whooshing), sometimes variable.
# A sensation of fullness or pressure in one or both ears.


Attacks of vertigo can be severe, incapacitating, and unpredictableIn some patients, attacks of vertigo can last for hours or days, and may be accompanied by an increase in the loudness of tinnitus and temporary, albeit significant, hearing loss in the affected ear(s).  Hearing may improve after an attack, but often becomes progressively worse.  Vertigo attacks are sometimes accompanied by [[nausea]], [[vomiting]], and [[sweating]].
* Ménière's often begins with one symptom, and gradually progressesA diagnosis may be made in the absence of all four classic symptoms. However, having several symptoms at once is more conclusive than having every individual symptom associated with the disease at a separate time.


Some sufferers experience what are informally known as "drop attacks" &mdash; a sudden, severe attack of dizziness or vertigo that causes the sufferer, if not seated, to fall. Patients may also experience the feeling of being pushed or pulled (Pulsion).
* Attacks of vertigo can be severe, incapacitating, and unpredictable. In some patients, attacks of vertigo can last for hours or days, and may be accompanied by an increase in the loudness of tinnitus and temporary, albeit significant, hearing loss in the affected ear(s). Hearing may improve after an attack, but often becomes progressively worse. Vertigo attacks are sometimes accompanied by [[nausea]], [[vomiting]], and [[sweating]].
Some patients may find it impossible to get up for some time, until the attack passes or medication takes effect. There is also the risk of injury from falling.  


In addition to hearing loss, sounds can seem tinny or distorted, and patients can experience unusual sensitivity to noises (hyperacusis).  Some sufferers also experience [[nystagmus]], or uncontrollable rhythmical and jerky eye movements, usually in the horizontal plane, reflecting the essential role of the balance system in coordinating eye movements.
* Some sufferers experience what are informally known as "drop attacks"&mdash; sudden, severe attacks of dizziness or vertigo that causes the sufferers, if not seated, to fall. Patients may also experience the feeling of being pushed or pulled (Pulsion). Some patients may find it impossible to get up for some time, until the attack passes or medication takes its effect.  There is also the associated risk of injury with falls   
 
* In addition to hearing loss, sounds can seem tinny or distorted, and patients can experience an unusual increased sensitivity to noises (hyperacusis).  Some sufferers also experience [[nystagmus]], or uncontrollable rhythmical and jerky eye movements, usually in the horizontal plane, reflecting an essential role of the balance system in coordinating eye movements.
 
* Other symptoms include the  so-called "[[brain fog]]" (temporary short term loss of memory, forgetfulness, and confusion), exhaustion and drowsiness, headaches, vision problems, and depression, the  latter symptoms are commonly associated with other chronic conditions
*Women may experience an increase in the frequency of episodes during pregnancy and menstruation, the most likely reasoning behind this exacerbation is the increased fluid retention seen with these conditions.


Other symptoms include so-called "[[brain fog]]" (temporary loss of short term memory, forgetfulness, and confusion), exhaustion and drowsiness, headaches, vision problems, and depression. Many of these latter symptoms are common to many chronic diseases.
==Differential Diagnosis==
==Differential Diagnosis==
{|
{|
Line 91: Line 92:
| colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |'''Peripheral'''
| colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |'''Peripheral'''
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Benign paroxysmal positional vertigo|BPPV]]<br><ref name="pmid20607044">{{cite journal |vauthors=Lee SH, Kim JS |title=Benign paroxysmal positional vertigo |journal=J Clin Neurol |volume=6 |issue=2 |pages=51–63 |date=June 2010 |pmid=20607044 |pmc=2895225 |doi=10.3988/jcn.2010.6.2.51 |url=}}</ref><ref name="pmid11771020">{{cite journal |vauthors=Chang MB, Bath AP, Rutka JA |title=Are all atypical positional nystagmus patterns reflective of central pathology? |journal=J Otolaryngol |volume=30 |issue=5 |pages=280–2 |date=October 2001 |pmid=11771020 |doi= |url=}}</ref><ref name="pmid24642523">{{cite journal |vauthors=Dorresteijn PM, Ipenburg NA, Murphy KJ, Smit M, van Vulpen JK, Wegner I, Stegeman I, Grolman W |title=Rapid Systematic Review of Normal Audiometry Results as a Predictor for Benign Paroxysmal Positional Vertigo |journal=Otolaryngol Head Neck Surg |volume=150 |issue=6 |pages=919–24 |date=June 2014 |pmid=24642523 |doi=10.1177/0194599814527233 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Benign paroxysmal positional vertigo|BPPV]]<br>


| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 106: Line 107:
* May be associated with [[nausea]], [[vomiting]], and [[Gait abnormality|gait instability]]
* May be associated with [[nausea]], [[vomiting]], and [[Gait abnormality|gait instability]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vestibular neuronitis|Vestibular neuritis]]<br><ref name="pmid18283159">{{cite journal |vauthors=Mandalà M, Nuti D, Broman AT, Zee DS |title=Effectiveness of careful bedside examination in assessment, diagnosis, and prognosis of vestibular neuritis |journal=Arch. Otolaryngol. Head Neck Surg. |volume=134 |issue=2 |pages=164–9 |date=February 2008 |pmid=18283159 |doi=10.1001/archoto.2007.35 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vestibular neuronitis|Vestibular neuritis]]<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
Line 119: Line 120:
* [[History and Physical examination|History/ Physical exam]]
* [[History and Physical examination|History/ Physical exam]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* May be associated with [[nausea]], [[vomiting]], [[Gait abnormality|gait instability]] and previous [[upper respiratory infection]]
* May be associated with [[nausea]], [[vomiting]], [[Gait abnormality|gait instability]]  
*Triggered by viral  [[upper respiratory infection|upper respiratory tract infection]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ramsay Hunt syndrome type II|HSV oticus]]<br><ref name="Wackym1997">{{cite journal|last1=Wackym|first1=Phillip A.|title=Molecular Temporal Bone Pathology: II. Ramsay Hunt Syndrome (Herpes Zoster Oticus)|journal=The Laryngoscope|volume=107|issue=9|year=1997|pages=1165–1175|issn=0023852X|doi=10.1097/00005537-199709000-00003}}</ref><ref name="ZhuPyatkevich2014">{{cite journal|last1=Zhu|first1=S.|last2=Pyatkevich|first2=Y.|title=Ramsay Hunt syndrome type II|journal=Neurology|volume=82|issue=18|year=2014|pages=1664–1664|issn=0028-3878|doi=10.1212/WNL.0000000000000388}}</ref><ref name="pmid2113244">{{cite journal |vauthors=Mishell JH, Applebaum EL |title=Ramsay-Hunt syndrome in a patient with HIV infection |journal=Otolaryngol Head Neck Surg |volume=102 |issue=2 |pages=177–9 |date=February 1990 |pmid=2113244 |doi=10.1177/019459989010200215 |url=}}</ref><ref name="TadaAoyagi2009">{{cite journal|last1=Tada|first1=Yuichiro|last2=Aoyagi|first2=Masaru|last3=Tojima|first3=Hitoshi|last4=Inamura|first4=Hiroo|last5=Saito|first5=Osamu|last6=Maeyama|first6=Hiroyuki|last7=Kohsyu|first7=Hidehiro|last8=Koike|first8=Yoshio|title=Gd-DTPA Enhanced MRI in Ramsay Hunt Syndrome|journal=Acta Oto-Laryngologica|volume=114|issue=sup511|year=2009|pages=170–174|issn=0001-6489|doi=10.3109/00016489409128326}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ramsay Hunt syndrome type II|HSV oticus]]<br>


| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 128: Line 130:
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Taste loss in the front two-thirds of the [[tongue]]
* loss of tastein the front two-thirds of the [[tongue]]
* [[Acute facial nerve paralysis]]
* [[Acute facial nerve paralysis]]
* [[Vesicles]] in the [[ear canal]], the [[tongue]], and/or [[hard palate]]
* [[Vesicles]] in the [[ear canal]], the [[tongue]], and/or [[hard palate]]
Line 134: Line 136:
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + [[Varicella zoster virus|VZV]] antibody titres
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + [[Varicella zoster virus|VZV]] antibody titres
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In [[Magnetic resonance imaging|MRI]] with [[gadolinium]] dye we may have enhancement of the [[facial nerve]] and [[cranial nerve VIII]]
*[[Magnetic resonance imaging|MRI]] with [[gadolinium]] contrast may show enhancement of the [[facial nerve]] and [[vestibulocochlear nerve]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History/ Physical exam]]
* [[History and Physical examination|History/ Physical exam]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* May be associated with [[otalgia]], [[dry mouth]], and [[dry eyes]]
* May be associated with [[otalgia]], [[dry mouth]] and [[dry eyes]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ménière's disease|Meniere disease]]<br><ref name="Watanabe1980">{{cite journal|last1=Watanabe|first1=Isamu|title=Ménière’s Disease|journal=ORL|volume=42|issue=1-2|year=1980|pages=20–45|issn=1423-0275|doi=10.1159/000275477}}</ref><ref name="pmid9487176">{{cite journal |vauthors=Saeed SR |title=Fortnightly review. Diagnosis and treatment of Ménière's disease |journal=BMJ |volume=316 |issue=7128 |pages=368–72 |date=January 1998 |pmid=9487176 |pmc=2665527 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ménière's disease|Meniere disease]]<br>


| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
Line 150: Line 152:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In [[CT scan]] we may see small or invisible [[vestibular aqueduct]]
*[[CT scan]] may show small or invisible [[vestibular aqueduct]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History/ Physical exam]]/ Rulling out other diagnoses
* [[History and Physical examination|History/ Physical exam]]
*Ruling out other CNS and ear pathologies.
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* May be associated with [[Nausea and vomiting|nausea]], [[Nausea and vomiting|vomiting]], and [[tinnitus]]
* May be associated with [[Nausea and vomiting|nausea]], [[Nausea and vomiting|vomiting]], and [[tinnitus]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion<br><ref name="DürrerPoláčková1971">{{cite journal|last1=Dürrer|first1=J.|last2=Poláčková|first2=J.|title=Labyrinthine Concussion|journal=ORL|volume=33|issue=3|year=1971|pages=185–190|issn=1423-0275|doi=10.1159/000274994}}</ref><ref name="pmid24653897">{{cite journal |vauthors=Choi MS, Shin SO, Yeon JY, Choi YS, Kim J, Park SK |title=Clinical characteristics of labyrinthine concussion |journal=Korean J Audiol |volume=17 |issue=1 |pages=13–7 |date=April 2013 |pmid=24653897 |pmc=3936518 |doi=10.7874/kja.2013.17.1.13 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion<br>


| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 166: Line 169:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* We may see other evidences of [[head trauma]] or [[temporal bone]] [[fracture]]
*[[CT scan]] may show evidence of [[head trauma]] or [[temporal bone]] [[fracture]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History/ Physical exam]]
* [[History and Physical examination|History/ Physical exam]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* It happens following blunt [[head trauma]]
* Follows blunt [[head trauma]]
* May be associated with [[dizziness]] or [[tinnitus]]
* May be associated with [[dizziness]] or [[tinnitus]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Perilymphatic fistula]]<br><ref name="FoxBalkany1988">{{cite journal|last1=Fox|first1=Eileen J.|last2=Balkany|first2=Thomas J.|last3=Arenberg|first3=Kaufman|title=The Tullio Phenomenon and Perilymph Fistula|journal=Otolaryngology–Head and Neck Surgery|volume=98|issue=1|year=1988|pages=88–89|issn=0194-5998|doi=10.1177/019459988809800115}}</ref><ref name="pmid11796947">{{cite journal |vauthors=Casselman JW |title=Diagnostic imaging in clinical neuro-otology |journal=Curr. Opin. Neurol. |volume=15 |issue=1 |pages=23–30 |date=February 2002 |pmid=11796947 |doi= |url=}}</ref><ref name="pmid3941579">{{cite journal |vauthors=Seltzer S, McCabe BF |title=Perilymph fistula: the Iowa experience |journal=Laryngoscope |volume=96 |issue=1 |pages=37–49 |date=January 1986 |pmid=3941579 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Perilymphatic fistula]]<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 186: Line 189:
* [[History and Physical examination|History/ Physical exam]]/[[Imaging]]
* [[History and Physical examination|History/ Physical exam]]/[[Imaging]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Can be a complication of a [[stapedectomy]], [[head injury]], or heavy lifting
* Complication of [[stapedectomy]], [[head injury]], or heavy lifting
* It may be provoked by [[Sneeze|sneezing]], lifting, straining, [[Cough|coughing]], and loud sounds
* It may be provoked by activities such as [[Sneeze|sneezing]], lifting, straining, [[Cough|coughing]], and loud sounds.        (Tullio phenomenon)
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal  
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal  
dehiscence syndrome<br><ref name="pmid15655395">{{cite journal |vauthors=Lempert T, von Brevern M |title=Episodic vertigo |journal=Curr. Opin. Neurol. |volume=18 |issue=1 |pages=5–9 |date=February 2005 |pmid=15655395 |doi= |url=}}</ref><ref name="pmid10680810">{{cite journal |vauthors=Watson SR, Halmagyi GM, Colebatch JG |title=Vestibular hypersensitivity to sound (Tullio phenomenon): structural and functional assessment |journal=Neurology |volume=54 |issue=3 |pages=722–8 |date=February 2000 |pmid=10680810 |doi= |url=}}</ref>
dehiscence syndrome<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 207: Line 210:
* It may be provoked by [[Valsalva maneuver]], [[Cough|coughing]], and [[Sneeze|sneezing]]
* It may be provoked by [[Valsalva maneuver]], [[Cough|coughing]], and [[Sneeze|sneezing]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysmia<br><ref name="HufnerBarresi2008">{{cite journal|last1=Hufner|first1=K.|last2=Barresi|first2=D.|last3=Glaser|first3=M.|last4=Linn|first4=J.|last5=Adrion|first5=C.|last6=Mansmann|first6=U.|last7=Brandt|first7=T.|last8=Strupp|first8=M.|title=Vestibular paroxysmia: Diagnostic features and medical treatment|journal=Neurology|volume=71|issue=13|year=2008|pages=1006–1014|issn=0028-3878|doi=10.1212/01.wnl.0000326594.91291.f8}}</ref><ref name="pmid23400324">{{cite journal |vauthors=Strupp M, von Stuckrad-Barre S, Brandt T, Tonn JC |title=Teaching neuroimages: Compression of the eighth cranial nerve causes vestibular paroxysmia |journal=Neurology |volume=80 |issue=7 |pages=e77 |date=February 2013 |pmid=23400324 |doi=10.1212/WNL.0b013e318281cc2c |url=}}</ref><ref name="pmid18809837">{{cite journal |vauthors=Hüfner K, Barresi D, Glaser M, Linn J, Adrion C, Mansmann U, Brandt T, Strupp M |title=Vestibular paroxysmia: diagnostic features and medical treatment |journal=Neurology |volume=71 |issue=13 |pages=1006–14 |date=September 2008 |pmid=18809837 |doi=10.1212/01.wnl.0000326594.91291.f8 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysmia<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 218: Line 221:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* We may see evidence of [[vestibulocochlear nerve]] compression on [[MRI]]
*[[MRI]] may show evidence of [[vestibulocochlear nerve]] compression  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History/ Physical exam]]/Imaging
* [[History and Physical examination|History/ Physical exam]]
*Imaging
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* It may be provoked by head turn or other action
* It may be provoked by head turning
* They respond well to treatment with [[carbamazepine]] or [[oxcarbazepine]]
* Responds well to treatment with [[carbamazepine]] or [[oxcarbazepine]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cogan syndrome]]<br><ref name="pmid2189159">{{cite journal |vauthors=Vollertsen RS |title=Vasculitis and Cogan's syndrome |journal=Rheum. Dis. Clin. North Am. |volume=16 |issue=2 |pages=433–9 |date=May 1990 |pmid=2189159 |doi= |url=}}</ref><ref name="HughesKinney1983">{{cite journal|last1=Hughes|first1=Gordon B.|last2=Kinney|first2=Sam E.|last3=Barna|first3=Barbara P.|last4=Tomsak|first4=Robert L.|last5=Calabrese|first5=Leonard H.|title=Autoimmune reactivity in Cogan's syndrome: A preliminary report|journal=Otolaryngology–Head and Neck Surgery|volume=91|issue=1|year=1983|pages=24–32|issn=0194-5998|doi=10.1177/019459988309100106}}</ref><ref name="MajoorAlbers2009">{{cite journal|last1=Majoor|first1=M. H. J. M.|last2=Albers|first2=F. W. J.|last3=Casselman|first3=J. W.|title=Clinical Relevance of Magnetic Resonance Imaging and Computed Tomography in Cogan's Syndrome|journal=Acta Oto-Laryngologica|volume=113|issue=5|year=2009|pages=625–631|issn=0001-6489|doi=10.3109/00016489309135875}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cogan syndrome]]<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | −
| style="background: #F5F5F5; padding: 5px; text-align: center;" | −
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 237: Line 241:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Increased [[ESR]] and  [[cryoglobulins]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Increased [[ESR]] and  [[cryoglobulins]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In [[CT scan]] we may see [[calcification]] or soft tissue attenuation obliterating the intralabyrinthine fluid spaces  
*[[CT scan]] may show  [[calcification]] or soft tissue attenuation obliterating the intralabyrinthine fluid spaces
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History/ Physical exam]]
* [[History and Physical examination|History/ Physical exam]]
Line 243: Line 247:
* It may cause [[Ménière's disease|Ménière]]-like attacks
* It may cause [[Ménière's disease|Ménière]]-like attacks
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vestibular schwannoma]]<br><ref>{{Cite journal
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vestibular schwannoma]]<br>
| author = [[Robert W. Foley]], [[Shahram Shirazi]], [[Robert M. Maweni]], [[Kay Walsh]], [[Rory McConn Walsh]], [[Mohsen Javadpour]] & [[Daniel Rawluk]]
| title = Signs and Symptoms of Acoustic Neuroma at Initial Presentation: An Exploratory Analysis
| journal = [[Cureus]]
| volume = 9
| issue = 11
| pages = e1846
| year = 2017
| month = November
| doi = 10.7759/cureus.1846
| pmid = 29348989
}}</ref><ref>{{Cite journal
| author = [[E. P. Lin]] & [[B. T. Crane]]
| title = The Management and Imaging of Vestibular Schwannomas
| journal = [[AJNR. American journal of neuroradiology]]
| volume = 38
| issue = 11
| pages = 2034–2043
| year = 2017
| month = November
| doi = 10.3174/ajnr.A5213
| pmid = 28546250
}}</ref>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 276: Line 258:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In [[CT scan]] we may see erosion, and widening of the [[Internal auditory meatus|internal acoustic meatus]]
*[[CT scan]] we may show  erosion, and widening of the [[Internal auditory meatus|internal acoustic meatus]]
* Hypointense [[mass]] on T1-weighted [[MRI]], and hyperintense [[mass]] on T2-weighted [[MRI]]
* T1-weighted [[MRI]] may show a hypointense mass lesion where as T-2 weighted MRI  shows a hyperintense [[mass]] lesion
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Imaging]]
* [[Imaging]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Gadolinium]]-enhanced [[MRI]] scan is definitive diagnostic test of [[Vestibular schwannoma|acoutic neuroma]]
* [[Gadolinium]]-enhanced [[MRI]] scan is the definitive diagnostic test for  [[Vestibular schwannoma|acoutic neuroma]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Otitis media]]<br><ref name="urlEar infection - acute: MedlinePlus Medical Encyclopedia">{{cite web |url=https://www.nlm.nih.gov/medlineplus/ency/article/000638.htm |title=Ear infection - acute: MedlinePlus Medical Encyclopedia |format= |work= |accessdate=}}</ref><ref name="pmid25213276">{{cite journal |vauthors=Rettig E, Tunkel DE |title=Contemporary concepts in management of acute otitis media in children |journal=Otolaryngol. Clin. North Am. |volume=47 |issue=5 |pages=651–72 |year=2014 |pmid=25213276 |pmc=4393005 |doi=10.1016/j.otc.2014.06.006 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Otitis media]]<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
Line 297: Line 279:
* [[History and Physical examination|History/ Physical exam]]
* [[History and Physical examination|History/ Physical exam]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Patient may show other [[signs]] and [[symptoms]] of [[upper respiratory infection]] such az [[cough]], [[nasal discharge]], and [[fever]]
* Patient may show other [[signs]] and [[symptoms]] of [[upper respiratory infection]] such as [[cough]], [[nasal discharge]], and [[fever]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity<br><ref name="pmid8597959">{{cite journal |vauthors=Ernfors P, Duan ML, ElShamy WM, Canlon B |title=Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3 |journal=Nat. Med. |volume=2 |issue=4 |pages=463–7 |date=April 1996 |pmid=8597959 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
Line 312: Line 294:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* May be associated with [[nausea]], [[vomiting]], and [[ataxia]]
* May be associated with [[nausea]], [[vomiting]], and [[ataxia]]
* It may be irreversible
* possibly irreversible
* [[Gentamicin]] is the most common one
* [[Gentamicin]] is the most common one
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy<br><ref name="pmid11343320">{{cite journal |vauthors=Oh AK, Lee H, Jen JC, Corona S, Jacobson KM, Baloh RW |title=Familial benign recurrent vertigo |journal=Am. J. Med. Genet. |volume=100 |issue=4 |pages=287–91 |date=May 2001 |pmid=11343320 |doi= |url=}}</ref><ref name="pmid3712538">{{cite journal |vauthors=Rutka JA, Barber HO |title=Recurrent vestibulopathy: third review |journal=J Otolaryngol |volume=15 |issue=2 |pages=105–7 |date=April 1986 |pmid=3712538 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
Line 328: Line 310:
* The underlying [[pathophysiology]] is unknown
* The underlying [[pathophysiology]] is unknown


* It may happen infrequently, every one to two years
* Frequency of episodes may vary, possibly an episode every one to two years.
* It may be associated with [[nausea]] and [[vomiting]]
* It may be associated with [[nausea]] and [[vomiting]]
* It may overlap with vestibular [[migraine]]
* It may show an overlap of  symptoms with vestibular [[migraine]]
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Central
! colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Central
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migrain<br><ref name="pmid14979299">{{cite journal |vauthors= |title=The International Classification of Headache Disorders: 2nd edition |journal=Cephalalgia |volume=24 Suppl 1 |issue= |pages=9–160 |date=2004 |pmid=14979299 |doi= |url=}}</ref><ref name="pmid22714135">{{cite journal |vauthors=Absinta M, Rocca MA, Colombo B, Copetti M, De Feo D, Falini A, Comi G, Filippi M |title=Patients with migraine do not have MRI-visible cortical lesions |journal=J. Neurol. |volume=259 |issue=12 |pages=2695–8 |date=December 2012 |pmid=22714135 |doi=10.1007/s00415-012-6571-x |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migraine<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |–
| style="background: #F5F5F5; padding: 5px; text-align: center;" |–
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 343: Line 325:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* They may have [[White matter|white-matter]] hyperintensities (WMHs) on [[MRI]]
*[[MRI]] may show [[White matter|white-matter]] hyper-intensities (WMHs)
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ICHD-3 criteria
* ICHD-3 criteria
Line 349: Line 331:
* It may be associated with [[anxiety]] and [[depression]]
* It may be associated with [[anxiety]] and [[depression]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo<br><ref name="pmid25795644">{{cite journal |vauthors=Tarnutzer AA, Lee SH, Robinson KA, Kaplan PW, Newman-Toker DE |title=Clinical and electrographic findings in epileptic vertigo and dizziness: a systematic review |journal=Neurology |volume=84 |issue=15 |pages=1595–604 |date=April 2015 |pmid=25795644 |pmc=4408281 |doi=10.1212/WNL.0000000000001474 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 361: Line 343:
* [[EEG]]
* [[EEG]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* They response well to anti-[[seizure]] drugs
* Respond well to anti-[[seizure|epileptic]] drugs
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple sclerosis]]<br><ref name="pmid11456302">{{cite journal |vauthors=McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS |title=Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis |journal=Ann. Neurol. |volume=50 |issue=1 |pages=121–7 |date=July 2001 |pmid=11456302 |doi= |url=}}</ref><ref name="pmid3985583">{{cite journal |vauthors=Barrett L, Drayer B, Shin C |title=High-resolution computed tomography in multiple sclerosis |journal=Ann. Neurol. |volume=17 |issue=1 |pages=33–8 |date=January 1985 |pmid=3985583 |doi=10.1002/ana.410170109 |url=}}</ref><ref name="pmid10449103">{{cite journal |vauthors=Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, McFarland HF, Paty DW, Simon JH, Wolinsky JS, Miller DH |title=The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis |journal=Neurology |volume=53 |issue=3 |pages=448–56 |date=August 1999 |pmid=10449103 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple sclerosis]]<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 371: Line 353:
* [[Lhermitte's sign]]
* [[Lhermitte's sign]]
* [[Spasticity]]
* [[Spasticity]]
* Increased [[reflexes]]  
*[[Hyperreflexia]]  
* [[Internuclear ophthalmoplegia]]
* [[Internuclear ophthalmoplegia]]
* [[Optic neuritis]]
* [[Optic neuritis]]
Line 377: Line 359:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Cerebral atrophy|Brain atrophy]] and some [[contrast]] enhancing plaques on [[CT scan]]
*[[CT scan]] shows brain atrophy and contrast enhanced demyelinating plaques  
* Cerebral plaques disseminating in space and time on [[MRI scan|MRI]]
*[[MRI scan|MRI]] showing cerebral plaques disseminating in time and space. 
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History and physical examination]]
* [[History and Physical examination|History and physical examination]]
Line 384: Line 366:
* [[CSF analysis]]
* [[CSF analysis]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[MS]] is at least two times more common among [[women]] than [[men]]
* [[MS]] is twice as prevalent in women as compared to men  
* The onset of [[symptoms]] is mostly between the age of fifteen to forty years, rarely before age fifteen or after age sixty
* The onset of [[symptoms]] is mostly between the age of fifteen to forty years and  rarely before the  age of fifteen or after the age of sixty years
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Brain tumor|Brain tumors]]<br><ref name="DunniwayWelling2016">{{cite journal|last1=Dunniway|first1=Heidi M.|last2=Welling|first2=D. Bradley|title=Intracranial Tumors Mimicking Benign Paroxysmal Positional Vertigo|journal=Otolaryngology–Head and Neck Surgery|volume=118|issue=4|year=2016|pages=429–436|issn=0194-5998|doi=10.1177/019459989811800401}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Brain tumor|Brain tumors]]<br>


| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
Line 399: Line 381:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* On [[CT scan]] most of the [[brain tumors]] appears as a hypodense mass lesions
* On [[CT scan]] most of the [[brain tumors]] appears as a hypodense mass lesions
* On [[MRI scan|MRI]] most of the [[brain tumors]] appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted [[MRI contrast agent|MRI]].
* On T1- weighted [[MRI scan|MRI]] most of the [[brain tumors]] appears as a hypointense or Isointense whereas on T2-weighted [[MRI contrast agent|MRI]] they  appear as hyperintense lesions
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Imaging]]
* [[Imaging]]
Line 405: Line 387:
* [[Biopsy forceps|Biopsy]]
* [[Biopsy forceps|Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Patieny may experience  [[headache]], [[seizures]], [[Visual disturbance|visual changes]] and changes in [[personality]], [[mood]] and [[concentration]]
* May experience  [[headache]], [[seizures]], [[Visual disturbance|visual changes]] and changes in [[personality]], [[mood]] and [[concentration]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cerebellar infarction]]/hemorrhage
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cerebellar infarction]]/hemorrhage
Line 418: Line 400:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Based on the time interval between [[stroke]] and [[imaging]] we may have different presentations
* Based on the time interval lapsed  between the onset of  [[stroke]] and [[imaging]] performed there may be different presentations
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Imaging]]
* [[Imaging]]
Line 436: Line 418:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Based on the time interval between [[stroke]] and [[imaging]] we may have different presentations
* Based on the time interval lapsed  between the onset of  [[stroke]] and [[imaging]] performed there may be different presentations
* For more information [[Ischemic stroke CT|click here]]
* For more information [[Ischemic stroke CT|click here]]


Line 444: Line 426:
* It may be associated with [[subclavian steal syndrome]]
* It may be associated with [[subclavian steal syndrome]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chiari malformation]]<br><ref name="pmid15034729">{{cite journal |vauthors=Caldarelli M, Di Rocco C |title=Diagnosis of Chiari I malformation and related syringomyelia: radiological and neurophysiological studies |journal=Childs Nerv Syst |volume=20 |issue=5 |pages=332–5 |date=May 2004 |pmid=15034729 |doi=10.1007/s00381-003-0880-4 |url=}}</ref><ref name="pmid18809020">{{cite journal |vauthors=Sarnat HB |title=Disorders of segmentation of the neural tube: Chiari malformations |journal=Handb Clin Neurol |volume=87 |issue= |pages=89–103 |date=2008 |pmid=18809020 |doi=10.1016/S0072-9752(07)87006-0 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chiari malformation]]<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 456: Line 438:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In [[CT scan]] we may see [[hydrocephalus]], herniated [[cerebellar tonsils]], and a flattened [[spinal cord]]
*[[CT scan]] we may show [[hydrocephalus]], herniated [[cerebellar tonsils]], and a flattened [[spinal cord]]
* In [[MRI]] we may see [[Cerebellar tonsil|cerebellar tonsillar]] [[herniation]], wedge shaped tonsils, syringohydromyelia, small [[posterior fossa]], obstructive [[hydrocephalus]], and [[brainstem]] anomalies
*[[MRI]] may show  [[Cerebellar tonsil|cerebellar tonsillar]] [[herniation]], wedge shaped tonsils, syringohydromyelia, small [[posterior fossa]], obstructive [[hydrocephalus]], and [[brainstem]] anomalies
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Imaging]]
* [[Imaging]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Patient may experience ringing in the [[Ear|ears]]
* May present with ringing in the [[Ear|ears]] (Tinnitus)
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Parkinson's disease|Parkinson]]<br><ref name="van Wensenvan Leeuwen2013">{{cite journal|last1=van Wensen|first1=E.|last2=van Leeuwen|first2=R.B.|last3=van der Zaag-Loonen|first3=H.J.|last4=Masius-Olthof|first4=S.|last5=Bloem|first5=B.R.|title=Benign paroxysmal positional vertigo in Parkinson's disease|journal=Parkinsonism & Related Disorders|volume=19|issue=12|year=2013|pages=1110–1112|issn=13538020|doi=10.1016/j.parkreldis.2013.07.024}}</ref><ref name="pmid3990948">{{cite journal |vauthors=Steiner I, Gomori JM, Melamed E |title=Features of brain atrophy in Parkinson's disease. A CT scan study |journal=Neuroradiology |volume=27 |issue=2 |pages=158–60 |date=1985 |pmid=3990948 |doi= |url=}}</ref><ref name="pmid15981079">{{cite journal |vauthors=Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S |title=MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease |journal=J. Neurol. |volume=253 |issue=1 |pages=26–32 |date=January 2006 |pmid=15981079 |doi=10.1007/s00415-005-0914-9 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Parkinson's disease|Parkinson]]<br>
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
Line 477: Line 459:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* On [[brain]] [[CT scan]], [[Parkinson's disease|Parkinson disease]] is characterized by cortical and subcortical [[atrophy]]
*[[CT scan]] is characterized by cortical and subcortical [[atrophy]]
* [[MRI]] findings in [[Parkinson disease]] are reduction in T2 relaxation time and reduced [[iron]] content in [[putamen]] and [[Globus pallidus|GPe]]
* [[MRI]] demonstrates a reduction in T2 relaxation time and reduced [[iron]] content in [[putamen]] and [[Globus pallidus|GPe]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History and physical examination]]
* [[History and Physical examination|History and physical examination]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Patients may present with slowness of movement ([[bradykinesia]]), shaking hands while they are at rest (resting [[tremor]]) and [[Muscle rigidity|muscle stiffness (rigidity)]].
* Patients may present with slowness of movement           ([[bradykinesia|bradykinesia),]]<nowiki/>resting [[tremor]]<nowiki/>and [[Muscle rigidity|muscle stiffness (rigidity)]].
|}
|}
'''ABBREVIATIONS'''
'''ABBREVIATIONS'''
Line 489: Line 471:


==Diagnosis==
==Diagnosis==
Many disorders have symptoms similar to Ménière's.  The diagnosis is usually established by clinical findings and [[medical history]]. However, a detailed oto-neurological examination, [[audiometry]] and head [[magnetic resonance imaging]] (MRI) scan should be performed to exclude a [[tumour]] of the [[cranial nerve VIII]] (vestibulocochlear nerve) or [[superior canal dehiscence]] which would cause similar symptoms.  Because there is no definitive test for Ménière's, it is only diagnosed when all other causes have been ruled out.
Many disorders have symptoms similar to Ménière's.  The diagnosis is usually established by clinical findings and [[medical history]]. However, a detailed oto-neurological examination, [[audiometry]] and head [[magnetic resonance imaging]] (MRI) scan should be performed to exclude a [[tumour]] of the [[cranial nerve VIII]] (vestibulocochlear nerve) or [[superior canal dehiscence]] which would cause similar symptoms.  Because there is no definitive test for Ménière's, it is only diagnosed when all other causes have been ruled out.


Ménière’s disease typically starts between the ages of 20 and 50 years. Men and women are affected in equal numbers.- ''American Academy of Otolaryngology−Head and Neck Surgery''
Ménière’s disease typically starts between the ages of 20 and 50 years. Men and women are affected in equal numbers.- ''American Academy of Otolaryngology−Head and Neck Surgery''


Ménière's typically begins between the ages of 30 and 60 and affects men slightly more than women.<ref>p.550, ''The Johns Hopkins Complete Home Guide to Symptoms & Remedies'', ed. Simeon Margolis, Black Dog & Levanthal Publishers (2004).</ref><ref>[http://www.doctoronline.nhs.uk/masterwebsite1Asp/targetpages/specialts/ent/menieres.asp U.K. NHS]</ref>
Ménière's typically begins between the ages of 30 and 60 years and affects men slightly more than women.


==Treatment==
==Treatment==
Initial treatment is aimed at both dealing with immediate symptoms and preventing recurrence of symptoms, and so will vary from patient to patient.  Doctors may recommend vestibular training, methods for dealing with tinnitus, stress reduction, hearing aids to deal with hearing loss, and medication to alleviate nausea and symptoms of vertigo.   
Several environmental and dietary changes are thought to reduce the frequency or severity of symptom outbreaks.  Most patients are advised to adopt a low-sodium diet<ref name="Maryland" />, typically one to two grams (1000-2000mg) at first, but diets as low as 400mg are not uncommon.  Patients are advised to avoid caffeine, alcohol and tobacco, all of which can aggravate symptoms of Ménière's.  Some recommend avoiding [[Aspartame]].  Patients are often prescribed a mild diuretic (sometimes vitamin B6).  Many patients will have allergy testing done to see if they are candidate for allergy desensitization as allergies have been shown to aggravate Ménière's symptoms.<ref name="pmid10652386">{{cite journal |author=Derebery MJ |title=Allergic management of Meniere's disease: an outcome study |journal=Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery |volume=122 |issue=2 |pages=174–82 |year=2000 |pmid=10652386 |doi=}}</ref>
Women may experience increased symptoms during [[pregnancy]] or shortly before [[menstruation]], probably due to increased fluid retention.


[[Lipoflavonoid]] is also recommended for treatment by some doctors.<ref>Williams HL, Maher FT, Corbin KB, et al: Eriodictyol glycoside in the treatment of Meniere’s disease. Ann Otol Rhinol Laryngol72:1082, 1963.</ref>
=== Medical Treatment ===
Initial treatment is targeted at relieving immediate symptoms and preventing recurrence of symptoms in the future and thus varies from patient to patient. Doctors may recommend vestibular training, methods for dealing with tinnitus, stress reduction, hearing aids to deal with hearing loss, and medication to alleviate nausea and symptoms of vertigo   


Many patients consider fluorescent lighting to be a trigger for symptomsThe plausibility of this can be explained by how important a part vision plays in the overall mechanism of human balance.
* Several environmental and dietary changes are thought to reduce the frequency or severity of symptom outbreaks.  Most patients are advised to adopt a low-sodium diet, typically one to two grams (1000-2000mg) at first, but diets as low as 400mg are not uncommonPatients are advised to avoid caffeine, alcohol and tobacco, all of which can aggravate symptoms of Ménière's.  Some clinicians recommend avoiding [[Aspartame]].
*Very often patients are prescribed a mild diuretic to decrease the inner ear fluid build up. 
*Some patients also undergo allergen testing during initial evaluation as allergies have been shown to aggravate Ménière's symptoms.<ref name="Maryland" />


[[Image:Endolymphaticshuntlabeledgg.jpg|left|thumb|250px x 250px|The '''endolymphatic shunt operation''' consists of opening the mastoid bone and identifying the endolymphatic sac which is located in the posterior fossa dura.  To find the sac, the sigmoid sinus is denuded of its bony cover except for a small rectangle of thin bone named Bill's Island, after Dr. William House.  The sigmoid sinus is then collapsed with gentle pressure and the sac exposed behind the posterior semicircular canal.  The sac is then incised and a shunt tube is inserted.  The picture on the right shows a Huang-Gibson tube with a one-way valve that allows fluid to seep out but not back into the sac.  This procedure decreases the endolymphatic fluid pressure.<ref>http://www.ghorayeb.com</ref>]]
* Lipoflavonoid, a natural bioflavonoid that contains some of the B vitamins namely B3, B6 and B12 of the B vitamin complex is recommended for treatment of the tinnitus component of the disease by some physicians.


Treatments aimed at lowering the pressure within the inner ear include [[antihistamine]]s, [[anticholinergic]]s, [[steroid]]s, and [[diuretic]]s.<ref name="Maryland" />  A [http://www.meniett.com/ medical device] that provides transtympanic micropressure pulses is now showing some promise and is becoming more widely used as a treatment for Ménière's.<ref name="pmid15949105">{{cite journal |author=Rajan GP, Din S, Atlas MD |title=Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience |journal=The Journal of laryngology and otology |volume=119 |issue=5 |pages=391–5 |year=2005 |pmid=15949105 |doi=10.1258/0022215053945868}}</ref>  
* Many patients consider fluorescent light as a trigger for their symptoms. The plausibility of this can be explained by the vital role that vision plays in the overall mechanism of human balance. Avoidance of such triggers can be one such way to prevent these symptoms.
* The anti herpesvirus drug Acyclovir has also been used with some success to treat Ménière's Disease.The likelihood of the effectiveness of the treatment was found to decrease with increasing duration of the disease possibly because of the overtime accumulation of viral damage to the inner ear and thus demonstrated that suppression of the virus made no significant difference to the symptoms if the exposure was present for prolonged periods. It was considered possible that long term treatment with an acyclovir (greater than six months) would be required to produce a remarkable reduction in symptomatology. Herpes viruses have the ability to remain dormant in nerve cells by a process known as [[HHV Latency Associated Transcript]]. Continued administration of the drug  could  prevent reactivation of the virus and allow for the possibility of an improvement in symptoms.
*Treatments aimed at lowering the pressure within the inner ear include [[antihistamine]]s, [[anticholinergic]]s, [[steroid]]s, and [[diuretic]]s. A [http://www.meniett.com/ medical device] that provides transtympanic micropressure pulses is now showing some promising results and is becoming more widely used as a treatment for Ménière's..<ref name="Maryland" />


[[Surgery]] may be recommended if medical management does not control vertigo. Injection of steroid medication behind the eardrum, or surgery to decompress the endolymphatic sac may be used for symptom reliefPermanent surgical destruction of the balance part of the affected ear can be performed for severe cases if only one ear is affected.   This can be achieved through chemical labyrinthectomy, in which a drug (such as [[gentamicin]]) that "kills" the vestibular apparatus is injected into the middle ear. The nerve to the balance portion of the inner ear can be cut ([[Vestibular nerve|vestibular]] [[neurectomy]]), or the inner ear itself can be surgically removed (labyrinthectomy)These treatments eliminate vertigo, but because they are destructive, they are used only as a last resortTypically balance returns to normal after these procedures, but hearing loss may continue to progress.<ref name="Maryland" />
[[Image:Endolymphaticshuntlabeledgg.jpg|center|thumb|The '''endolymphatic shunt operation''' consists of opening the mastoid bone and identifying the endolymphatic sac which is located in the posterior fossa duraTo find the sac, the sigmoid sinus is denuded of its bony cover except for a small rectangle of thin bone named Bill's Island, after Dr. William House. The sigmoid sinus is then collapsed with gentle pressure and the sac exposed behind the posterior semicircular canalThe sac is then incised and a shunt tube is insertedThe picture on the right shows a Huang-Gibson tube with a one-way valve that allows fluid to seep out but not back into the sac.  This procedure decreases the endolymphatic fluid pressure.]]<br />
=== Surgery ===


The anti herpesvirus drug [[Aciclovir]] has also been used with some success to treat Ménière's Disease<ref name=" Shichinohe "/>. The likelihood of the effectiveness of the treatment was found to decrease with increasing duration of the disease possibly because the accumulation of viral damage to the inner ear over time meant that suppression of the virus made no significant difference to the symptoms. Morphological changes to the inner ear of Ménière's sufferers have also been found which it was considered likely to have resulted from attack by a [[herpes simplex virus]]<ref name = "pmid11464320" />. It was considered possible that long term treatment with an acyclovir (greater than six months) would be required to produce an appreciable effect on symptoms. Herpes viruses have the ability to remain dormant in nerve cells by a process known as [[HHV Latency Associated Transcript]].  Continued administration of the drug should prevent reactivation of the virus and allow for the possibility of an improvement in symptoms. Another consideration is that different strains of a herpes virus can have different characteristics which may result in differences in the precise effects of the virus. Further confirmation that Aciclovir can have a positive effect on Ménière's symptoms has been reported<ref name="pmid18235200">{{cite journal |author= Gacek RR |title= Evidence for a viral neuropathy in recurrent vertigo |journal=ORL J Otorhinolaryngol Relat Spec. |volume=70 |issue=1 |pages=6–14 |year=2008 |pmid=18235200 }}</ref>.
* Surgery may be recommended if medical management does not control vertigo.


==Progression==
* Injection of steroid medication behind the eardrum, or surgery to decompress the endolymphatic sac may be used for symptom relief.  Permanent surgical destruction of the balance part of the affected ear can be performed for severe or refractory cases if only one ear is affected.  This can be achieved through chemical labyrinthectomy, in which a drug (such as [[gentamicin]]) that "kills" the vestibular apparatus is injected into the middle ear. The nerve responsible for the balance component of the inner ear can be cut ([[Vestibular nerve|vestibular]] [[neurectomy]]), or the inner ear itself can be surgically removed (labyrinthectomy).
Progression of Ménière's is unpredictable: symptoms may worsen, disappear altogether, or remain the same.
*These treatments eliminate vertigo, but since they are typically destructive they are implemented only as a last resort. Usually balance returns to normal after these procedures, but hearing loss may continue to progress.<ref name="Maryland" />


Sufferers whose Ménière's began with one or two of the classic symptoms may develop others with time.  Attacks of vertigo can become worse and more frequent over time, resulting in loss of employment, loss of the ability to drive, and inability to travel.  Some patients become largely housebound.  Hearing loss can become more profound and may become permanent.  Some patients become deaf in the affected ear.  Tinnitus can also worsen over time.  Some patients with unilateral symptoms, as many as fifty percent by some estimates, will develop symptoms in both ears.  Some of these will become totally deaf.
==Progression/Prognosis ==
Progression of Ménière's is unpredictable: symptoms may worsen, undergo complete resolution or remain the same.


Yet the disease may end spontaneously and never repeat again.  Some sufferers find that after eight to ten years their vertigo attacks gradually become less frequent and less severe; in some patients they disappear completely. In some patients, symptoms of tinnitus will also disappear, and hearing will stabilize (though usually with some permanent loss).
Patients with classical one or two symptoms may develop other symptoms over time.  Attacks of vertigo can progressively worsen and increase in frequency over time, resulting in unemployment and the inability to drive and travel.  Some patients become largely housebound.  Hearing loss can become profound and more permanent.  Some patients may also develop deafness in the affected ear. It is estimated that in fifty percent of the cases patients with unilateral symptoms will develop symptoms bilaterally. Tinnitus is also known to worsen over time. Some patients reported that after 8-10 years the vertigo attacks gradually became less frequent in severity; some patients reported that the symptoms disappeared completely. In some patients, symptoms of tinnitus disappear overtime and the hearing partially stabilises although typically with some permanent loss.


==See also==
==See also==
Line 557: Line 543:
[[Category:Overview complete]]
[[Category:Overview complete]]
[[Category:Disease]]
[[Category:Disease]]
<references />

Latest revision as of 22:17, 11 August 2020

Ménière's disease
ICD-10 H81.0
ICD-9 386.0
OMIM 156000
DiseasesDB 8003
MedlinePlus 000702

Template:Search infobox

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sukaina Furniturewala, MBBS[2]

Overview

Ménière's disease is a disorder affecting the sensory organ within the inner ear responsible for balance and hearing. It is characterized by episodes of dizziness, tinnitus and progressive hearing loss, usually in one ear. This disturbance in the normal physiological functioning of the inner ear can be attributed to an increase in volume and pressure in the endolymph of the inner ear. The term "Ménière's" takes it origin after the French physician Prosper Ménière, who first reported that vertigo was caused by disorders of the inner ear in an article published in 1861.

Historical Background

Ménière's disease had been recognized prior to 1972 but the information available on its prevalence and understanding remained rather vague. Committees at the Academy of Ophthalmology and Otolaryngology made set criteria for diagnosing Ménière's, as well as defining two sub categories of Ménière's: cochlear (without vertigo) and vestibular (without deafness).

In 1972, the academy defined criteria for diagnosing Ménière's disease as:

  1. Fluctuating, progressive, sensorineural deafness.
  2. Episodic, characteristic definitive spells of vertigo lasting 20 minutes to 24 hours without loss of consciousness and associated with the presence of vestibular nystagmus .
  3. Usually tinnitus.
  4. Attacks are characterized by periods of remission and exacerbation.

In 1985, this list changed to alter wording, such as "deafness" changed to "hearing loss associated with tinnitus, characteristic of low frequencies" and requiring more than one attack of vertigo to diagnose. Finally in 1995, the list was again altered to allow for its documentation based on various degrees of probability of having the disease:

  1. Certain - Definite disease with histopathological confirmation
  2. Definite - Requires two or more definitive episodes of vertigo with hearing loss plus tinnitus and/or aural fullness
  3. Probable - Only one definitive episode of vertigo and the other symptoms and signs
  4. Possible - Definitive vertigo with no associated hearing loss

Cause

  • Physiological -The exact cause of Ménière's disease is not known, but it is believed to be related to endolymphatic hydrops or excessive fluid in the inner ear. Several theories describing the causative mechanism have been proposed and documented, One such theory includes the decreased absorption or the increased production of the endolymph within the endolymphatic sac. This in-turn contributes to the swelling of the endolymphatic sac or other tissues in the vestibular system of the inner ear, a system responsible for the body's sense of balance which is disrupted a s a result of this pathology.
  • Anatomical - Longitudinal blockage in the structures responsible for the drainage of the endolymph causing an increase in the hydrostatic pressure within the endolymphatic sac was another theory that was proposed to describe the possible structural cause behind the disease.
  • Head trauma
  • Infectious - It has also been proposed that Ménière's symptoms could be the result of damage caused by a the large family of DNA virus, herpesviridae. Herpesviridae is prevalent in the dormant state in a majority of the population. It is suggested that the virus is reactivated when the immune system is depressed due to stressors such as trauma, infection or surgery (under general anaesthesia). Morphological changes to the inner ear of Ménière's sufferers has been found and is likely considered to have resulted from attack by the herpes simplex virus. Symptoms then develop as the virus degrades the structure of the inner ear. Another consideration of utmost importance is that the different strains of herpes virus have different characteristics and in-turn different pathophysiological effects on the inner ear sensory organ system.
  • Middle ear and Upper Respiratory Tract Infections.
  • Medications - Aspirin use
  • Substance use - Tobacco and alcohol use
  • Electrolyte imbalance - Excessive levels of potassium in the body (usually caused by the consumption of potassium rich foods)can also exacerbate these symptoms.

Symptoms

The symptoms of Ménière's are variable; not all sufferers experience the same symptoms. However, so-called "classic Ménière's" is considered to comprise of the following four symptoms:

  1. Periodic episodes of rotary vertigo (the abnormal sensation of movement) or dizziness.
  2. Fluctuating, progressive, unilateral (in one ear) or bilateral (in both ears) hearing loss, sensorineural in origin and often initially in the low frequency ranges.
  3. Unilateral or bilateral tinnitus (the perception of noises, often ringing, roaring, or whooshing), sometimes variable.
  4. A sensation of fullness or pressure in one or both ears.
  • Ménière's often begins with one symptom, and gradually progresses. A diagnosis may be made in the absence of all four classic symptoms. However, having several symptoms at once is more conclusive than having every individual symptom associated with the disease at a separate time.
  • Attacks of vertigo can be severe, incapacitating, and unpredictable. In some patients, attacks of vertigo can last for hours or days, and may be accompanied by an increase in the loudness of tinnitus and temporary, albeit significant, hearing loss in the affected ear(s). Hearing may improve after an attack, but often becomes progressively worse. Vertigo attacks are sometimes accompanied by nausea, vomiting, and sweating.
  • Some sufferers experience what are informally known as "drop attacks"— sudden, severe attacks of dizziness or vertigo that causes the sufferers, if not seated, to fall. Patients may also experience the feeling of being pushed or pulled (Pulsion). Some patients may find it impossible to get up for some time, until the attack passes or medication takes its effect. There is also the associated risk of injury with falls
  • In addition to hearing loss, sounds can seem tinny or distorted, and patients can experience an unusual increased sensitivity to noises (hyperacusis). Some sufferers also experience nystagmus, or uncontrollable rhythmical and jerky eye movements, usually in the horizontal plane, reflecting an essential role of the balance system in coordinating eye movements.
  • Other symptoms include the so-called "brain fog" (temporary short term loss of memory, forgetfulness, and confusion), exhaustion and drowsiness, headaches, vision problems, and depression, the latter symptoms are commonly associated with other chronic conditions
  • Women may experience an increase in the frequency of episodes during pregnancy and menstruation, the most likely reasoning behind this exacerbation is the increased fluid retention seen with these conditions.

Differential Diagnosis

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging
Acute onset Recurrency Nystagmus Hearing problems
Peripheral
BPPV
+ + +/−
Vestibular neuritis
+ +/− + /−

(unilateral)

  • + Head thrust test
HSV oticus
+ +/− +/− + VZV antibody titres
Meniere disease
+/− + +/− + (Progressive)
Labyrinthine concussion
+ +
Perilymphatic fistula
+/− + +
  • CT scan may show fluid around the round window recess
Semicircular canal

dehiscence syndrome

+/− + +

(air-bone gaps on audiometry)

Vestibular paroxysmia
+ + +/−

(Induced by hyperventilation)

Cogan syndrome
+ +/− + Increased ESR and cryoglobulins
  • CT scan may show calcification or soft tissue attenuation obliterating the intralabyrinthine fluid spaces
Vestibular schwannoma
+ +/− +
Otitis media
+ +/− Increased acute phase reactants
Aminoglycoside toxicity
+ +
Recurrent vestibulopathy
+
  • Frequency of episodes may vary, possibly an episode every one to two years.
  • It may be associated with nausea and vomiting
  • It may show an overlap of symptoms with vestibular migraine
Central
Vestibular migraine
+ +/− +/−
  • ICHD-3 criteria
Epileptic vertigo
+ +/−
Multiple sclerosis
+ +/− Elevated concentration of CSF oligoclonal bands
  • CT scan shows brain atrophy and contrast enhanced demyelinating plaques
  • MRI showing cerebral plaques disseminating in time and space.
  • MS is twice as prevalent in women as compared to men
  • The onset of symptoms is mostly between the age of fifteen to forty years and rarely before the age of fifteen or after the age of sixty years
Brain tumors
+/− + + + Cerebral spinal fluid (CSF) may show cancerous cells
  • On CT scan most of the brain tumors appears as a hypodense mass lesions
  • On T1- weighted MRI most of the brain tumors appears as a hypointense or Isointense whereas on T2-weighted MRI they appear as hyperintense lesions
Cerebellar infarction/hemorrhage + ++/−
  • Based on the time interval lapsed between the onset of stroke and imaging performed there may be different presentations
Brain stem ischemia + +/−
  • Based on the time interval lapsed between the onset of stroke and imaging performed there may be different presentations
  • For more information click here
Chiari malformation
+ +
  • May present with ringing in the ears (Tinnitus)
Parkinson
+
  • CT scan is characterized by cortical and subcortical atrophy
  • MRI demonstrates a reduction in T2 relaxation time and reduced iron content in putamen and GPe

ABBREVIATIONS

VZV= Varicella zoster virus, MRI= Magnetic resonance imaging, ESR= Erythrocyte sedimentation rate, EEG= Electroencephalogram, CSF= Cerebrospinal fluid, GPe= Globus pallidus externa, ICHD= International Classification of Headache Disorders

Diagnosis

Many disorders have symptoms similar to Ménière's. The diagnosis is usually established by clinical findings and medical history. However, a detailed oto-neurological examination, audiometry and head magnetic resonance imaging (MRI) scan should be performed to exclude a tumour of the cranial nerve VIII (vestibulocochlear nerve) or superior canal dehiscence which would cause similar symptoms. Because there is no definitive test for Ménière's, it is only diagnosed when all other causes have been ruled out.

Ménière’s disease typically starts between the ages of 20 and 50 years. Men and women are affected in equal numbers.- American Academy of Otolaryngology−Head and Neck Surgery

Ménière's typically begins between the ages of 30 and 60 years and affects men slightly more than women.

Treatment

Medical Treatment

Initial treatment is targeted at relieving immediate symptoms and preventing recurrence of symptoms in the future and thus varies from patient to patient. Doctors may recommend vestibular training, methods for dealing with tinnitus, stress reduction, hearing aids to deal with hearing loss, and medication to alleviate nausea and symptoms of vertigo   

  • Several environmental and dietary changes are thought to reduce the frequency or severity of symptom outbreaks. Most patients are advised to adopt a low-sodium diet, typically one to two grams (1000-2000mg) at first, but diets as low as 400mg are not uncommon. Patients are advised to avoid caffeine, alcohol and tobacco, all of which can aggravate symptoms of Ménière's. Some clinicians recommend avoiding Aspartame.
  • Very often patients are prescribed a mild diuretic to decrease the inner ear fluid build up.
  • Some patients also undergo allergen testing during initial evaluation as allergies have been shown to aggravate Ménière's symptoms.[1]
  • Lipoflavonoid, a natural bioflavonoid that contains some of the B vitamins namely B3, B6 and B12 of the B vitamin complex is recommended for treatment of the tinnitus component of the disease by some physicians.
  • Many patients consider fluorescent light as a trigger for their symptoms. The plausibility of this can be explained by the vital role that vision plays in the overall mechanism of human balance. Avoidance of such triggers can be one such way to prevent these symptoms.
  • The anti herpesvirus drug Acyclovir has also been used with some success to treat Ménière's Disease.The likelihood of the effectiveness of the treatment was found to decrease with increasing duration of the disease possibly because of the overtime accumulation of viral damage to the inner ear and thus demonstrated that suppression of the virus made no significant difference to the symptoms if the exposure was present for prolonged periods. It was considered possible that long term treatment with an acyclovir (greater than six months) would be required to produce a remarkable reduction in symptomatology. Herpes viruses have the ability to remain dormant in nerve cells by a process known as HHV Latency Associated Transcript. Continued administration of the drug could prevent reactivation of the virus and allow for the possibility of an improvement in symptoms.
  • Treatments aimed at lowering the pressure within the inner ear include antihistamines, anticholinergics, steroids, and diuretics. A medical device that provides transtympanic micropressure pulses is now showing some promising results and is becoming more widely used as a treatment for Ménière's..[1]
The endolymphatic shunt operation consists of opening the mastoid bone and identifying the endolymphatic sac which is located in the posterior fossa dura. To find the sac, the sigmoid sinus is denuded of its bony cover except for a small rectangle of thin bone named Bill's Island, after Dr. William House. The sigmoid sinus is then collapsed with gentle pressure and the sac exposed behind the posterior semicircular canal. The sac is then incised and a shunt tube is inserted. The picture on the right shows a Huang-Gibson tube with a one-way valve that allows fluid to seep out but not back into the sac. This procedure decreases the endolymphatic fluid pressure.


Surgery

  • Surgery may be recommended if medical management does not control vertigo.
  • Injection of steroid medication behind the eardrum, or surgery to decompress the endolymphatic sac may be used for symptom relief. Permanent surgical destruction of the balance part of the affected ear can be performed for severe or refractory cases if only one ear is affected. This can be achieved through chemical labyrinthectomy, in which a drug (such as gentamicin) that "kills" the vestibular apparatus is injected into the middle ear. The nerve responsible for the balance component of the inner ear can be cut (vestibular neurectomy), or the inner ear itself can be surgically removed (labyrinthectomy).
  • These treatments eliminate vertigo, but since they are typically destructive they are implemented only as a last resort. Usually balance returns to normal after these procedures, but hearing loss may continue to progress.[1]

Progression/Prognosis

Progression of Ménière's is unpredictable: symptoms may worsen, undergo complete resolution or remain the same.

Patients with classical one or two symptoms may develop other symptoms over time. Attacks of vertigo can progressively worsen and increase in frequency over time, resulting in unemployment and the inability to drive and travel. Some patients become largely housebound. Hearing loss can become profound and more permanent. Some patients may also develop deafness in the affected ear. It is estimated that in fifty percent of the cases patients with unilateral symptoms will develop symptoms bilaterally. Tinnitus is also known to worsen over time. Some patients reported that after 8-10 years the vertigo attacks gradually became less frequent in severity; some patients reported that the symptoms disappeared completely. In some patients, symptoms of tinnitus disappear overtime and the hearing partially stabilises although typically with some permanent loss.

See also

References

  1. 1.0 1.1 1.2

Template:Diseases of the ear and mastoid process


cs:Ménierova nemoc de:Morbus Menière hr:Ménièreova bolest it:Sindrome di Ménière he:מחלת מנייר nl:Ziekte van Ménière no:Ménières sykdom fi:Ménièren tauti sv:Ménières sjukdom Template:SIB

Template:WikiDoc Sources